prc30 on Nostr: China Afternoon Missive I had mentioned in a previous Note that there are a number of ...
China Afternoon Missive
I had mentioned in a previous Note that there are a number of pressure points China can apply in a retaliatory trade conflict with America. Specifically, I mentioned that China manufactures 50% of the world’s antibiotics. I also mentioned that China had learned its lesson during Covid and the blowback that came when limits were placed on exporting PPE to the United States. For the time being, such an approach – direct pain to the American populace – is to be eschewed.
Come to find out even the minimal tariff of 10% on all Chinese imports has elicited a quick reaction from America’s medical and hospital communities.
Quoting from this Reuters article “The American Hospital Association wrote in a letter to Trump on Tuesday that the tariffs will affect cancer and heart medicines as well as antibiotics like amoxicillin from China.”
As we can clearly see here, China maintains a sizeable market share in various medicines and apparently nothing was done to correct this overreliance even after accounting for the PPE shortage during Covid.
Now think about just how many American industries are facing the exact same issue. We aren’t talking about import bans mind you. This, right here, is only a reaction simply to the levying of a 10% tariff meaning higher prices. Seems as though profit margins are about to be squeezed hard across a number of industries, or higher prices will be passed along to consumers meaning stickier inflation.
Anyway, it has been one hell of a busy week.
https://www.reuters.com/world/us/trump-faces-pressure-us-industry-over-china-tariff-medicines-2025-02-06/
I had mentioned in a previous Note that there are a number of pressure points China can apply in a retaliatory trade conflict with America. Specifically, I mentioned that China manufactures 50% of the world’s antibiotics. I also mentioned that China had learned its lesson during Covid and the blowback that came when limits were placed on exporting PPE to the United States. For the time being, such an approach – direct pain to the American populace – is to be eschewed.
Come to find out even the minimal tariff of 10% on all Chinese imports has elicited a quick reaction from America’s medical and hospital communities.
Quoting from this Reuters article “The American Hospital Association wrote in a letter to Trump on Tuesday that the tariffs will affect cancer and heart medicines as well as antibiotics like amoxicillin from China.”
As we can clearly see here, China maintains a sizeable market share in various medicines and apparently nothing was done to correct this overreliance even after accounting for the PPE shortage during Covid.
Now think about just how many American industries are facing the exact same issue. We aren’t talking about import bans mind you. This, right here, is only a reaction simply to the levying of a 10% tariff meaning higher prices. Seems as though profit margins are about to be squeezed hard across a number of industries, or higher prices will be passed along to consumers meaning stickier inflation.
Anyway, it has been one hell of a busy week.
https://www.reuters.com/world/us/trump-faces-pressure-us-industry-over-china-tariff-medicines-2025-02-06/